Correlation Between Karyopharm Therapeutics and Vera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Vera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Vera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Vera Therapeutics, you can compare the effects of market volatilities on Karyopharm Therapeutics and Vera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Vera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Vera Therapeutics.

Diversification Opportunities for Karyopharm Therapeutics and Vera Therapeutics

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Karyopharm and Vera is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Vera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vera Therapeutics and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Vera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vera Therapeutics has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Vera Therapeutics go up and down completely randomly.

Pair Corralation between Karyopharm Therapeutics and Vera Therapeutics

Given the investment horizon of 90 days Karyopharm Therapeutics is expected to under-perform the Vera Therapeutics. In addition to that, Karyopharm Therapeutics is 1.25 times more volatile than Vera Therapeutics. It trades about -0.65 of its total potential returns per unit of risk. Vera Therapeutics is currently generating about -0.29 per unit of volatility. If you would invest  4,727  in Vera Therapeutics on September 25, 2024 and sell it today you would lose (535.00) from holding Vera Therapeutics or give up 11.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Karyopharm Therapeutics  vs.  Vera Therapeutics

 Performance 
       Timeline  
Karyopharm Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Karyopharm Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Vera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Vera Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Karyopharm Therapeutics and Vera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Karyopharm Therapeutics and Vera Therapeutics

The main advantage of trading using opposite Karyopharm Therapeutics and Vera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Vera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vera Therapeutics will offset losses from the drop in Vera Therapeutics' long position.
The idea behind Karyopharm Therapeutics and Vera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments